GGT1 and neoplasm: Recently, two meta-analyses demonstrated that patients with a high serum GGT level not only had a poor prognosis (in terms of overall survival, recurrence-free survival, and disease-free survival) but also had several unfavorable clinicopathological features, including vascular invasion and the tumor burden [5,6].